Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:41 UTC |
---|
HMDB ID | HMDB0014640 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Oxycodone |
---|
Description | Oxycodone is only found in individuals that have used or taken this drug. It is a semisynthetic derivative of codeine that acts as a narcotic analgesic more potent and addicting than codeine. [PubChem]Oxycodone acts as a weak agonist at mu, kappa, and delta opioid receptors within the central nervous system (CNS). Oxycodone primarily affects mu-type opioid receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as oxycodone also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (kappa-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (mu and delta receptor agonist). This results in hyperpolarization and reduced neuronal excitability. |
---|
Structure | [H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(-)-14-Hydroxydihydrocodeinone | ChEBI | 4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one | ChEBI | 4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one | ChEBI | Dihydro-14-hydroxycodeinone | ChEBI | Dihydrohydroxycodeinone | ChEBI | Dihydroxycodeinone | ChEBI | Oxicodona | ChEBI | Oxycodonum | ChEBI | 4,5a-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one | Generator | 4,5Α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one | Generator | Dihydrohydroxycondeinone | HMDB | Dihydrone | HMDB | PTI-821 | HMDB | Dinarkon | HMDB | Oxiconum | HMDB | Oxycone | HMDB | Oxycontin | HMDB | Theocodin | HMDB | Eucodal | HMDB | Oxycodeinon | HMDB | Oxycodone hydrochloride | HMDB | Pancodine | HMDB | Purdue frederick brand OF oxycodone | HMDB |
|
---|
Chemical Formula | C18H21NO4 |
---|
Average Molecular Weight | 315.3636 |
---|
Monoisotopic Molecular Weight | 315.147058165 |
---|
IUPAC Name | (1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one |
---|
Traditional Name | (1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one |
---|
CAS Registry Number | 76-42-6 |
---|
SMILES | [H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O |
---|
InChI Identifier | InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1 |
---|
InChI Key | BRUQQQPBMZOVGD-XFKAJCMBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenanthrenes and derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenanthrenes and derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenanthrenes and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenanthrene
- Isoquinolone
- Tetralin
- Coumaran
- Anisole
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Cyclic alcohol
- Tertiary alcohol
- Tertiary aliphatic amine
- Tertiary amine
- 1,2-aminoalcohol
- Ketone
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Ether
- Alcohol
- Organonitrogen compound
- Organopnictogen compound
- Organooxygen compound
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 218 - 220 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 5.59 g/L | Not Available | LogP | 0.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 168.3 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Oxycodone,1TMS,isomer #1 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(=O)CC[C@@]35O[Si](C)(C)C | 2559.2 | Semi standard non polar | 33892256 | Oxycodone,1TMS,isomer #2 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C(=C(O[Si](C)(C)C)CC[C@@]34O)OC1=C25 | 2599.4 | Semi standard non polar | 33892256 | Oxycodone,1TMS,isomer #3 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(O[Si](C)(C)C)=CC[C@@]35O | 2566.3 | Semi standard non polar | 33892256 | Oxycodone,2TMS,isomer #1 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C(=C(O[Si](C)(C)C)CC[C@@]34O[Si](C)(C)C)OC1=C25 | 2551.9 | Semi standard non polar | 33892256 | Oxycodone,2TMS,isomer #1 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C(=C(O[Si](C)(C)C)CC[C@@]34O[Si](C)(C)C)OC1=C25 | 2622.5 | Standard non polar | 33892256 | Oxycodone,2TMS,isomer #1 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C(=C(O[Si](C)(C)C)CC[C@@]34O[Si](C)(C)C)OC1=C25 | 3228.5 | Standard polar | 33892256 | Oxycodone,2TMS,isomer #2 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(O[Si](C)(C)C)=CC[C@@]35O[Si](C)(C)C | 2553.0 | Semi standard non polar | 33892256 | Oxycodone,2TMS,isomer #2 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(O[Si](C)(C)C)=CC[C@@]35O[Si](C)(C)C | 2586.7 | Standard non polar | 33892256 | Oxycodone,2TMS,isomer #2 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(O[Si](C)(C)C)=CC[C@@]35O[Si](C)(C)C | 3200.4 | Standard polar | 33892256 | Oxycodone,1TBDMS,isomer #1 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(=O)CC[C@@]35O[Si](C)(C)C(C)(C)C | 2811.2 | Semi standard non polar | 33892256 | Oxycodone,1TBDMS,isomer #2 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C(=C(O[Si](C)(C)C(C)(C)C)CC[C@@]34O)OC1=C25 | 2864.4 | Semi standard non polar | 33892256 | Oxycodone,1TBDMS,isomer #3 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(O[Si](C)(C)C(C)(C)C)=CC[C@@]35O | 2821.3 | Semi standard non polar | 33892256 | Oxycodone,2TBDMS,isomer #1 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C(=C(O[Si](C)(C)C(C)(C)C)CC[C@@]34O[Si](C)(C)C(C)(C)C)OC1=C25 | 3027.7 | Semi standard non polar | 33892256 | Oxycodone,2TBDMS,isomer #1 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C(=C(O[Si](C)(C)C(C)(C)C)CC[C@@]34O[Si](C)(C)C(C)(C)C)OC1=C25 | 3085.8 | Standard non polar | 33892256 | Oxycodone,2TBDMS,isomer #1 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C(=C(O[Si](C)(C)C(C)(C)C)CC[C@@]34O[Si](C)(C)C(C)(C)C)OC1=C25 | 3423.2 | Standard polar | 33892256 | Oxycodone,2TBDMS,isomer #2 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(O[Si](C)(C)C(C)(C)C)=CC[C@@]35O[Si](C)(C)C(C)(C)C | 3029.4 | Semi standard non polar | 33892256 | Oxycodone,2TBDMS,isomer #2 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(O[Si](C)(C)C(C)(C)C)=CC[C@@]35O[Si](C)(C)C(C)(C)C | 2984.2 | Standard non polar | 33892256 | Oxycodone,2TBDMS,isomer #2 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(O[Si](C)(C)C(C)(C)C)=CC[C@@]35O[Si](C)(C)C(C)(C)C | 3388.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Oxycodone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9061000000-5297e69aa2cc5152068f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Oxycodone GC-MS (1 TMS) - 70eV, Positive | splash10-00fr-9538000000-1b9bf2a9c0682b6738c4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Oxycodone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Oxycodone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Oxycodone GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Oxycodone GC-MS ("Oxycodone,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-014i-6975000000-ecd49efa58246c903e23 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone LC-ESI-QTOF , positive-QTOF | splash10-014i-0009000000-d55749fa4d1f47ce2244 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone LC-ESI-QTOF , positive-QTOF | splash10-00kb-0095000000-83c78e9e15857145cc78 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone LC-ESI-QTOF , positive-QTOF | splash10-0002-0090000000-ad908ecfa38c7efce138 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone LC-ESI-QTOF , positive-QTOF | splash10-0006-0390000000-88d302b8770cb7121937 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone LC-ESI-QTOF , positive-QTOF | splash10-03fu-0790000000-4af50b834ee854320001 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 10V, Positive-QTOF | splash10-014i-0009000000-60bc25dea256a8ba83bb | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 30V, Positive-QTOF | splash10-0002-0090000000-fccf9384aae73d4c8009 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 50V, Positive-QTOF | splash10-03fu-0790000000-7931a551d5483e7067a3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 50V, Positive-QTOF | splash10-03fu-0690000000-3d8d447a366cdf1fdb74 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 20V, Positive-QTOF | splash10-00kb-0096000000-55405b387941a889b750 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 40V, Positive-QTOF | splash10-0006-0390000000-1f6f5ca02d934d0d4537 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 35V, Positive-QTOF | splash10-0002-0093000000-a61df116baabe44f4c3a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 50V, Positive-QTOF | splash10-03fu-0690000000-7dc7939fd86861c02ab4 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 40V, Positive-QTOF | splash10-0006-0390000000-fff1638b31b7719ed170 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 10V, Positive-QTOF | splash10-014i-0009000000-377e0e430e1a242d1475 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 20V, Positive-QTOF | splash10-00kb-0095000000-f6e8b2a3a26565536bcb | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 40V, Positive-QTOF | splash10-0006-0390000000-97492063e89cfb7228d2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 50V, Positive-QTOF | splash10-03fu-0690000000-f855a40fc07061c8e49a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Oxycodone 30V, Positive-QTOF | splash10-0002-0090000000-e6d1bf0cfddfd668c1e7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxycodone 10V, Positive-QTOF | splash10-00kb-0095000000-187a15135033fe090084 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxycodone 20V, Positive-QTOF | splash10-0002-1091000000-36b41da08ca2b913a212 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxycodone 40V, Positive-QTOF | splash10-0a5c-5090000000-a251627d2dc7a2e0750c | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxycodone 10V, Negative-QTOF | splash10-03di-0029000000-9ffd2b473cfe2ec06b32 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxycodone 20V, Negative-QTOF | splash10-01ot-1096000000-a01cf940a0da1fca0ffd | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxycodone 40V, Negative-QTOF | splash10-052g-2090000000-da3286e89dfed1ee6a32 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
|
---|